(Q45392678)

14 December 2017

title

Clinicopathological features of elderly patients with hepatitis C virus-related hepatocellular carcinoma (English)

1 reference

14 December 2017

1 reference

13

Toshimasa Asahara

1 reference

14 December 2017

14

Koji Arihiro

1 reference

14 December 2017

15

Kazuaki Chayama

1 reference

14 December 2017

9

Michio Imamura

1 reference

14 December 2017

2

Hiroshi Aikata

1 reference

14 December 2017

5

Tomokazu Kawaoka

1 reference

14 December 2017

10

Yoshiiku Kawakami

1 reference

14 December 2017

11

Shoichi Takahashi

1 reference

14 December 2017

1

Daiki Miki

1 reference

14 December 2017

Kiminori Uka

3

1 reference

14 December 2017

Hiromi Saneto

4

1 reference

14 December 2017

Takahiro Azakami

6

1 reference

14 December 2017

Shintaro Takaki

7

1 reference

14 December 2017

Soo Cheol Jeong

8

1 reference

14 December 2017

Toshiyuki Itamoto

12

1 reference

14 December 2017

language of work or name

1 reference

23 July 2008

1 reference

Journal of Gastroenterology

14 December 2017

published in

1 reference

14 December 2017

volume

43

1 reference

14 December 2017

issue

7

1 reference

14 December 2017

page(s)

550-557

1 reference

Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00535-008-2194-5

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-008-2194-5

High prevalence of hepatitis B and C viral markers in Japanese patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-008-2194-5

Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-008-2194-5

Association between chronic hepatitis C infection and hepatocellular carcinoma in a Scottish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-008-2194-5

On the role of aging in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-008-2194-5

Risk Factors for Hepatocellular Carcinoma among Patients with Chronic Liver Disease

21 January 2018

1 reference

12 December 2020

A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis

1 reference

12 December 2020

Serum antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma

1 reference

12 December 2020

Impact of aging on the development of hepatocellular carcinoma in patients with posttransfusion chronic hepatitis C.

1 reference

12 December 2020

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study.

1 reference

12 December 2020

Hepatitis C-associated hepatocellular carcinoma

1 reference

12 December 2020

Impact of aging on the development of hepatocellular carcinoma in patients with hepatitis C virus infection in Japan

1 reference

12 December 2020

Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death.

1 reference

12 December 2020

Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.

1 reference

12 December 2020

Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis

1 reference

12 December 2020

Telomere reduction in human liver tissues with age and chronic inflammation

1 reference

12 December 2020

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group

1 reference

12 December 2020

Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups

1 reference

12 December 2020

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

1 reference

12 December 2020

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

1 reference

12 December 2020

A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan

1 reference

12 December 2020

Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C. A long term follow-up study after histologic diagnosis

1 reference

12 December 2020

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

12 December 2020

Multivariate analysis of risk factors for hepatocellular carcinoma in patients with hepatitis C virus-related liver cirrhosis

1 reference

12 December 2020

Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.

1 reference

12 December 2020

Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis

1 reference

12 December 2020

Development and validation of a model to diagnose cirrhosis in patients with hepatitis C

1 reference

12 December 2020

Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma

1 reference

12 December 2020

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

12 December 2020

Viral pathogenesis of hepatocellular carcinoma in the United States

1 reference

12 December 2020

High frequency of antibodies to the hepatitis C virus among patients with hepatocellular carcinoma

1 reference

12 December 2020

Hepatitis C virus infection is associated with the development of hepatocellular carcinoma

1 reference

12 December 2020

Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States.

1 reference

12 December 2020

Classification of chronic hepatitis: diagnosis, grading and staging

1 reference

12 December 2020

Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection

1 reference

12 December 2020

Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma

1 reference

12 December 2020

Reduction of telomeric repeats as a possible predictor for development of hepatocellular carcinoma: convenient evaluation by slot-blot analysis

1 reference

12 December 2020

10.1007/S00535-008-2194-5

Identifiers

DOI

1 reference

14 December 2017

1 reference